AMRX
Amneal Pharmaceuticals, Inc.
19.80$
-0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.3% | 12.1% | 11.3% | 22.7% | 15.0% | 0.1% | 19.0% | 11.6% | 2.9% | 14.4% | 10.6% | 11.3% | |
| 2.6% | 2.9% | 3.2% | 4.4% | 8.3% | 12.7% | 12.2% | 11.1% | 10.9% | 9.6% | 8.5% | 7.4% | |
| – | – | 2.1% | 0.5% | 10.1% | 1.3% | 1.0% | 1.4% | 1.4% | 1.1% | 1.0% | 1.1% | |
| 1.2% | 1.9% | 2.3% | 1.7% | 18.1% | 40.3% | 6.4% | 5.4% | 6.0% | – | – | – | |
| -11.9% | -14.2% | -14.9% | -0.1% | 0.4% | -7.4% | -3.1% | -6.4% | -2.7% | -2.0% | -0.1% | -6.8% | |
| 10.1% | 13.5% | 12.2% | 11.1% | 5.8% | 6.0% | 3.1% | 2.3% | 4.1% | 2.9% | 2.7% | 2.3% | |
| -15.4% | -15.7% | -12.2% | -9.5% | -23.8% | -1.2% | -15.9% | -9.3% | -7.9% | -2.9% | -2.3% | -3.7% | |
| 30.9% | 29.8% | 19.7% | 36.3% | 11.0% | 0.0% | – | – | 0.2% | – | – | – | |
| 0.0% | 11.5% | 0.9% | 0.1% | -0.5% | -0.1% | 0.0% | -0.1% | -0.2% | -0.1% | -0.3% | – | |
| 38.0% | 27.4% | 18.5% | 27.7% | 29.2% | -1.7% | 8.8% | 0.0% | 3.8% | 0.9% | -6.6% | 3.4% | |
| 6.1% | -2.9% | -1.9% | -9.2% | 17.3% | -2.8% | 6.6% | -6.6% | -4.8% | -8.9% | -7.6% | -1.0% | |
| 4.5% | -6.5% | -2.7% | 3.9% | 8.5% | -4.1% | 9.8% | -4.3% | -10.0% | 2.7% | 0.7% | 6.4% | |
| 4.2% | -1.4% | -0.9% | 11.6% | 9.2% | -5.9% | 15.9% | 9.3% | -1.2% | 11.5% | 7.9% | 8.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.